Severe Decompensated Chronic Heart Failure

Also known as: Chronic, severe Decompensated Heart Failure

Drug	Drug Name	Drug Description
DB00922	Levosimendan	A calcium sensitizer indicated to treat acutely decompensated severe chronic heart failure.

Drug	Drug Name	Target	Type
DB00922	Levosimendan	Troponin C, slow skeletal and cardiac muscles	target
DB00922	Levosimendan	ATP-sensitive inward rectifier potassium channel 11	target
DB00922	Levosimendan	ATP-sensitive inward rectifier potassium channel 8	target
DB00922	Levosimendan	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	target

Drug	Drug Name	Phase	Status	Count